We found that the HSD3B1 gene was upregulated in the resistant samples, indicating the increased expression of HSD3B1 in breast cancer patients on treatment with the non-steroidal AI drugs (anastrozole and letrozole). Here, HSD3B1 is linked to breast cancer.